Exchange Announcement • 06 Oct 2026 05:15
S-1 | IPO Registration
Exchange Announcement • 26 Sep 2026 05:08
Annual Report (Form 10-K | Period ending 2026-06-30)
No more filings
𝛼SK or SearchENTITY
Propanc Biopharma (PPCB US)
Propanc Biopharma (PPCB US)
2
Analysis
Health Care • United States
Propanc Biopharma, Inc. is a development-stage healthcare company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. Its lead product candidate, PRP, is a novel formulation involving pro-enzymes, which are the inactive precursors of enzymes.
morex